Please note that 02xl.com provides this information for the benefit of the disease community. 02xl.com is not a medical provider or health care facility and thus can neither diagnose any disease or disorder nor endorse or recommend any specific medical treatments. Patients must rely on the personal and individualized medical advice of their qualified health care professionals before seeking any information related to their particular diagnosis, cure or treatment of a condition or disorder.
Harjutsalo V, Pongrac Barlovic D, Groop PH. Long-term population-based trends in the incidence of cardiovascular disease in individuals with type 1 diabetes from Finland: a retrospective, nationwide, cohort study. Lancet Diabetes Endocrinol. 2021;9(9):575–85.
Livingstone SJ, Levin D, Looker HC, Lindsay RS, Wild SH, Joss N, et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008–2010. JAMA. 2015;313(1):37–44.
FinnDiane Study Group, Groop PH, Thomas M, Feodoroff M, Forsblom C, Harjutsalo V. Excess mortality in patients with type 1 diabetes without albuminuria-separating the contribution of early and late risks. Diabetes Care. 2018;41(4):748–54.
Nathan DM, Cleary PA, Backlund JYC, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643–53.
Lind M, Svensson AM, Kosiborod M, Gudbjörnsdottir S, Pivodic A, Wedel H, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371(21):1972–82.
Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–59.
Huang D, Huang YQ, Zhang QY, Cui Y, Mu TY, Huang Y. Association between long-term visit-to-visit hemoglobin A1c and cardiovascular risk in type 2 diabetes: the ACCORD trial. Front Cardiovasc Med. 2021;8:777233.
Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593–603.
Wadén J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, Groop PH, et al. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes. 2009;58(11):2649–55.
Horton WB, Snell-Bergeon JK. HbA1c variability metrics predict coronary artery calcium and cardiovascular events in type 1 diabetes: the CACTI study. J Clin Endocrinol Metab. 2023. https://doi.org/10.1210/clinem/dgad019.
Walker GS, Cunningham SG, Sainsbury CAR, Jones GC. HbA1c variability is associated with increased mortality and earlier hospital admission in people with Type 1 diabetes. Diabet Med J Br Diabet Assoc. 2017;34(11):1541–5.
Rotbain Curovic V, Theilade S, Winther SA, Tofte N, Tarnow L, Jorsal A, et al. Visit-to-visit variability of clinical risk markers in relation to long-term complications in type 1 diabetes. Diabet Med J Br Diabet Assoc. 2021;38(5):e14459.
Steineck I, Cederholm J, Eliasson B, Rawshani A, Eeg-Olofsson K, Svensson AM, et al. Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study. BMJ. 2015;22(350):h3234.
Papachristoforou E, Lambadiari V, Maratou E, Makrilakis K. Association of glycemic indices (Hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications. J Diabetes Res. 2020;2020:7489795.
Vatner SF, Zhang J, Vyzas C, Mishra K, Graham RM, Vatner DE. vascular stiffness in aging and disease. Front Physiol. 2021;7(12): 762437.
Tynjälä A, Forsblom C, Harjutsalo V, Groop PH, Gordin D, FinnDiane Study Group. Arterial stiffness predicts mortality in individuals with type 1 diabetes. Diabetes Care. 2020;43(9):2266–71.
Tougaard NH, Theilade S, Winther SA, Tofte N, Ahluwalia TS, Hansen TW, et al. Carotid-femoral pulse wave velocity as a risk marker for development of complications in type 1 diabetes mellitus. J Am Heart Assoc. 2020;9(19): e017165.
Tynjälä A, Forsblom C, Harjutsalo V, Groop PH, Gordin D. Response to comment on comment on Tynjälä et al. Arterial Stiffness predicts mortality in individuals with type 1 diabetes 2020;43:2266-2271. Diabetes Care. 2021;44(4):71–2.
Wakasugi S, Mita T, Katakami N, Okada Y, Yoshii H, Osonoi T, et al. Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes. Cardiovasc Diabetol. 2021;20(1):15.
Foreman YD, van Doorn WPTM, Schaper NC, van Greevenbroek MMJ, van der Kallen CJH, Henry RMA, et al. Greater daily glucose variability and lower time in range assessed with continuous glucose monitoring are associated with greater aortic stiffness: the Maastricht Study. Diabetologia. 2021;64(8):1880–92.
Zhang Y, Wu S, Li M, Wang T, Xu M, Lu J, et al. Long-term glycemic variability is associated with arterial stiffness in Chinese adults. Front Endocrinol. 2021;12:711540.
Gordin D, Rönnback M, Forsblom C, Mäkinen V, Saraheimo M, Groop PH. Glucose variability, blood pressure and arterial stiffness in type 1 diabetes. Diabetes Res Clin Pract. 2008;80(3):e4-7.
Cesana F, Giannattasio C, Nava S, Soriano F, Brambilla G, Baroni M, et al. Impact of blood glucose variability on carotid artery intima media thickness and distensibility in type 1 diabetes mellitus. Blood Press. 2013;22(6):355–61.
Helleputte S, Calders P, Rodenbach A, Marlier J, Verroken C, De Backer T, et al. Time-varying parameters of glycemic control and glycation in relation to arterial stiffness in patients with type 1 diabetes. Cardiovasc Diabetol. 2022;21(1):277.
Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588–605.
Mena L, Pintos S, Queipo NV, Aizpúrua JA, Maestre G, Sulbarán T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005;23(3):505–11.
Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens. 1998;16(12 Pt 2):2079–84.
Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30(3):445–8.
Gorst C, Kwok CS, Aslam S, Buchan I, Kontopantelis E, Myint PK, et al. Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis. Diabetes Care. 2015;38(12):2354–69.
Monnier LO, Owens D, Colette C, Bonnet F. Glycaemic variabilities: key questions in pursuit of clarity. Diabetes Metab. 2021;47(6):101283.
McCarter RJ, Hempe JM, Chalew SA. Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: an analysis of data from the diabetes control and complications trial. Diabetes Care. 2006;29(2):352–5.
Tokutsu A, Okada Y, Torimoto K, Tanaka Y. Relationship between glycemic intraday variations evaluated in continuous glucose monitoring and HbA1c variability in type 2 diabetes: pilot study. Diabetol Metab Syndr. 2021;13(1):45.
Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813–20.
Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681–7.
Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57(5):1349–54.
Valente T, Valente F, Lucchesi MBB, Punaro GR, Mouro MG, Gabbay MAL, et al. Relationship between short and long-term glycemic variability and oxidative stress in type 1 diabetes mellitus under daily life insulin treatment. Arch Endocrinol Metab. 2021;65(5):570–8.
Chang CM, Hsieh CJ, Huang JC, Huang IC. Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus. Acta Diabetol. 2012;49(Suppl 1):S171-177.
Rodrigues R, de Medeiros LA, Cunha LM, da Garrote-Filho MS, Bernardino Neto M, Jorge PT, et al. Correlations of the glycemic variability with oxidative stress and erythrocytes membrane stability in patients with type 1 diabetes under intensive treatment. Diabetes Res Clin Pract. 2018;144:153–60.
Reddy MA, Zhang E, Natarajan R. Epigenetic mechanisms in diabetic complications and metabolic memory. Diabetologia. 2015;58(3):443–55.
Long C, Tang Y, Huang J, Liu S, Xing Z. Association of long-term visit-to-visit variability of HbA1c and fasting glycemia with hypoglycemia in type 2 diabetes mellitus. Front Endocrinol. 2022;13:975468.
International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 2019;7(5):385–96.
Ceriello A, Novials A, Ortega E, La Sala L, Pujadas G, Testa R, et al. Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes. Diabetes. 2012;61(11):2993–7.
Ceriello A, Novials A, Ortega E, Pujadas G, La Sala L, Testa R, et al. Hyperglycemia following recovery from hypoglycemia worsens endothelial damage and thrombosis activation in type 1 diabetes and in healthy controls. Nutr Metab Cardiovasc Dis NMCD. 2014;24(2):116–23.
Hypoglycemia in the Diabetes Control and Complications Trial. The diabetes control and complications trial research group. Diabetes. 1997;46(2):271–86.
Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the diamond randomized clinical trial. JAMA. 2017;317(4):371–8.
Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the gold randomized clinical trial. JAMA. 2017;317(4):379–87.
Scott ES, McGrath RT, Januszewski AS, Calandro D, Hardikar AA, O’Neal DN, et al. HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment. BMJ Open. 2019;9(12):e033059.
Watanabe H, Takahara M, Katakami N, Shimomura I. Changes of HbA1c variability after the switch to a longer-acting insulin analog in people with type 1 diabetes. J Diabetes Investig. 2023;14(2):259–62. https://doi.org/10.1111/jdi.13941.
Penttilä IM, Halonen T, Punnonen K, Tiikkainen U. Best use of the recommended IFCC reference method, material and values in HbA1C analyses. Scand J Clin Lab Invest. 2005;65(6):453–62.
Share your experience. Everybody’s experience of Overweight & Obesity is different. There are many ways to address people’s lived experience of Overweight & Obesity, that must work for the individual. Sharing your story can help change perspectives and inspire others who may feel alone and unrepresented. You can also hear from other people about their experience of Overweight & Obesity.
Thanks for being there: We need your help. The 02xl Overweigt & Obesity
Community continues to grow but revenues have never been harder to maintain.
With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords. Our news coverage takes time and effort to publish 365 days a year. If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.